Saudi Arabia vs Senegal: The number of people with susceptibility test result for rifampicin
Saudi Arabia
33.85
in 2021
Senegal
30.79
in 2021
Saudi Arabia rank
129th
Senegal rank
132nd
The number of people with susceptibility test result for rifampicin over time
- Saudi Arabia
- Senegal
How they compare
Saudi Arabia currently reports 33.85 against 30.79 in Senegal, a difference of 3.06.
That makes Saudi Arabia's figure about 1.1 times Senegal's.
Across all 5 years both countries report, Saudi Arabia has been ahead every year.
Saudi Arabia ranks 129th and Senegal ranks 132nd of 146 countries.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 59.92 | 24.99 | 34.93 | Saudi Arabia |
| 2020s | 35.33 | 23.63 | 11.69 | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Saudi Arabia or Senegal?
- Saudi Arabia, at 33.85 against 30.79 in Senegal as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Saudi Arabia and Senegal?
- 3.06, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Senegal?
- 5 years are reported by both, from 2017 to 2021.
- How do Saudi Arabia and Senegal rank globally for the number of people with susceptibility test result for rifampicin?
- Saudi Arabia ranks 129th and Senegal ranks 132nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.